Microbial delivery system

Details for Australian Patent Application No. 2001219510 (hide)

Owner Allertein Therapeutics, LLC

Inventors Caplan, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2001219510

PCT Pub. Number WO01/66136

Priority 60/195,035 06.04.00 US; 09/731,375 06.12.00 US

Filing date 6 December 2000

Wipo publication date 17 September 2001

Acceptance publication date 14 June 2007

International Classifications

A61K 39/35 (2006.01) Medicinal preparations containing antigens or antibodies - Allergens

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

5 June 2003 Change of Name(s) of Applicant(s), Section 104

  Panacea Pharmaceuticals, Llc. The name of the applicant has been changed to SEER Pharmaceuticals, LLC. 2002

4 January 2007 Assignment before Grant

  SEER Pharmaceuticals, LLC The application has been assigned to Allertein Therapeutics, LLC 2002

14 June 2007 Application Accepted

  Published as AU-B-2001219510

11 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001219520-Enhanced efficacy aluminum-zirconium antiperspirants and methods for making

2001219460